top of page
Bladder


French Randomized Trial Between ACT and AMS 800 AUS

LATEST NEWS
July 4, 2016
First patients enrolled in French Randomized Trial Between Uromedica’s Adjustable Continence Therapy (ACT) and Boston Scientific’s AMS 800 Artificial Urinary Sphincter (AUS)
Link:
bottom of page